News

Neuroendocrine Cancer Specialist Dr. Satya Das Presents Grand Rounds at Vanderbilt University

Have you wondered what it’s like to attend Grand Rounds dedicated to neuroendocrine cancer?  NET expert Satya (Nanu) Das, MD, MSCI, Assistant Professor of Medicine, Vanderbilt University Medical Center and Lead of the Neuroendocrine Tumor and PRRT…

Work and Cancer — Free, Virtual Conference, June 24, 2022

Join Cancer + Careers when they present the 12th Annual National Conference on Work and Cancer on Friday, June 24, 2022.  This free, virtual, day-long event is open to patients, caregivers, healthcare professionals, advocates, employers/HR and …

Ask the NET Expert – May 2022

The Carcinoid Cancer Foundation is excited to have launched a new web-based program for the neuroendocrine tumor (NET) community – Ask the NET Expert. Each month, we are featuring a different physician who …

SNMMI Patient Education Day — Hybrid (In-Person and Virtual)

The Society of Nuclear Medicine and Molecular Imaging will offer a special Patient Education Day on Sunday, June 12 as part of its 2022 Annual Meeting. This free event offers patients and caregivers a unique opportunity to learn about the role of nuclear…

New Appointment for NET Expert Dr. Boris Naraev

Congratulations to Dr. Boris Naraev upon being appointed Medical Oncology Leader – Gastrointestinal, Neuroendocrine, and Rare Cancers Program at the Anderson Family Cancer Institute in Jupiter, Florida. Dr. Naraev previously led the Neuroendocrine…

If I Listened to My Doctor, I Would Be Dead Right Now

Taryn knew she needed a biopsy right away.  Being an advocate for oneself is often the deciding factor in getting a proper neuroendocrine  diagnosis.  READ MORE

…

The Passing of Dr. Thomas O’Dorisio

It is with great sadness that we share the passing of Dr. Thomas O’Dorisio, a pioneer and leader in the field of neuroendocrine cancer; a compassionate and dedicated physician; an outstanding colleague at the University of Iowa; and beloved husband to…

New NET Research Collaboration

Exciting news about a new research collaboration to discover and develop novel therapies targeting immune checkpoint proteins for the treatment of neuroendocrine tumors and other cancers.  The collaboration was announced by NexImmune Inc., a clinical-stage…

Second Generation Immunohistochemical Markers: Reflections from Clinical Implementation

This article from pathologist Carl Christofer Juhlin, MD, PhD, of Karolinska Institutet in Sweden identifies second-generation neuroendocrine immunohistochemical markers.   These markers can help identify the site of primary neuroendocrine…

New Online Survey For Carcinoid Syndrome Patients, Open Through February 12

You can make a difference in how a clinical trial is designed! Share your thoughts today by participating in a new survey for neuroendocrine cancer patients with Carcinoid Syndrome. The survey will be online through February 12. Read more here, https://t.e2ma.net/…/13668e89c4ceb31e31b3598f2f3b10f1…